Anti-angiogenic agents in second-line treatment for metastatic colorectal cancer: the optimization of pharmacological costs
Crossref DOI link: https://doi.org/10.1007/s00384-018-3077-8
Published Online: 2018-05-26
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Giuliani, Jacopo
Bonetti, Andrea
Text and Data Mining valid from 2018-05-26
Article History
Accepted: 2 May 2018
First Online: 26 May 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.